Health officials in Panama are puzzled over the 18 deaths caused by an unknown sickness. Of the 18, 13 died last week suffering from fever, diarrhoea and partial paralysis.
According to the Health Minister Camilo Alleyne, kidney and nervous tissue damage was detected by the tests conducted on the 18 victims, which suggested poisoning.
"The studies of kidney and nervous tissue showed damage that suggests a toxic effect," Mr Alleyne said, saying there were no signs that the sickness was contagious.
Advertisement
The mysterious illness was reported first a month back and it seems to affect the elderly men undergoing treatment for high blood pressure, diabetes and kidney disorders. Most of them were taking several treatments at a time.
Health Minister Camilo Alleyne said, "Officials are recalling Lisinopril tablets from pharmacies, hospitals and private clinics across Panama as scientists are testing the drug for toxic agents that may have poisoned 30 people."
"The cause is still not completely confirmed," Alleyne told a news conference late on Friday. "We decided as a safety precaution to withdraw this medicine from use."
"Some 7,000 Panamanians have public health service prescriptions for Lisinopril."
The number of private patients on this drug is not known. Scientists from Panama and the U.S. working on the case have rejected diseases like dengue fever, influenza and West Nile virus.
Source: Medindia
GYT
The number of private patients on this drug is not known. Scientists from Panama and the U.S. working on the case have rejected diseases like dengue fever, influenza and West Nile virus.
Source: Medindia
GYT
Advertisement
Advertisement
|
Advertisement
Latest General Health News
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.
A genetic variant in a patient protected from autosomal dominant Alzheimer's disease (ADAD) suggests a role for RELN signaling in resilience to dementia.